HARRISBURG, Pa., June 21 (UPI) -- A U.S. policy barring gay men from donating blood is drawing criticism from gay activists, blood banks and some medical officials.

FREMONT, Calif., Jan. 4 (UPI) -- A unit of Johnson & Johnson disclosed two additional deaths of patients in a clinical trial of its heart failure drug Natrecor, a report said Wednesday.

ARMONK, N.Y., Oct. 10 (UPI) -- The IBM Corp. in Armonk, N.Y., reportedly plans to pledge not to use genetic information in hiring or determining eligibility for healthcare plans.

NEW YORK, Sept. 12 (UPI) -- A clinical trial drug apparently worked for a Parkinson 's disease patient but its maker allegedly decided to take it away from him, reports CBS Television.

WASHINGTON, June 8 (UPI) -- The first large-scale survey of scientific misconduct suggests a significant proportion of U.S. scientists routinely engages in questionable behavior, such as altering data due to pressure from funding sources, that threatens the integrity of scientific s

WASHINGTON, May 27 (UPI) -- Although they do not know it yet, the technology that allowed Jonah and Gabrielle to be born is tangled up in a raging moral and political debate over when life begins -- a debate fundamental to the controversy about stem-cell research, abortion and ferti

WASHINGTON, May 3 (UPI) -- Some of the human embryonic stem-cell lines approved for federally funded research may not meet newly recommended ethical criteria for conducting that research -- a conflict that could limit access to the cell lines even further and impede progress in the

WASHINGTON, April 26 (UPI) -- New ethical guidelines for U.S. human stem-cell research could be used by proponents to urge the Bush administration to ease its research restrictions.

WASHINGTON, April 26 (UPI) -- New ethical guidelines for conducting human embryonic stem-cell research issued Tuesday by the National Academy of Sciences may have little impact on scientists, but experts think they will be used by patient groups and other proponents to urge the Bush a